Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07527130
C11 ER176 PET in Evaluating Neuroinflammation in Patients With Post-COVID Syndrome
Sponsor: Mayo Clinic
View on ClinicalTrials.gov
Summary
The purpose of this research is to find out if Positron Emission Tomography (PET) imaging with an investigational drug called C-11 ER176 can help us learn more about Post-COVID Syndrome.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
10
Start Date
2026-05
Completion Date
2027-12
Last Updated
2026-04-14
Healthy Volunteers
No
Conditions
Interventions
DRUG
C11 ER176 Tracer
C11 ER176 tracer will be administered by IV, followed by PET imaging of the brain to evaluate for neuroinflammation
Locations (1)
Mayo Clinic
Rochester, Minnesota, United States